GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
322.72B
USLCX
Price
$45.25
Change
+$0.09 (+0.20%)
Updated
Jul 16 closing price
Net Assets
2.09B
Interact to see
Advertisement

GFACX vs USLCX

Header iconGFACX vs USLCX Comparison
Open Charts GFACX vs USLCXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets322.72B
JHancock U.S. Global Leaders Growth C
Price$45.25
Change+$0.09 (+0.20%)
VolumeN/A
Net Assets2.09B
GFACX vs USLCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. USLCX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and USLCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 323B vs. USLCX (2.09B). GFACX (0.00) and USLCX (0.00) have matching dividends . GFACX was incepted earlier than USLCX: GFACX (24 years) vs USLCX (23 years). USLCX (1.89) is less costly to investors than GFACX (1.36). USLCX is a more actively managed with annual turnover of: 29.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than USLCX: GFACX (250) vs USLCX (1000). GFACX annual gain was more profitable for investors over the last year : 7.11 vs. USLCX (-12.72). GFACX return over 5 years is better than : 35.91 vs. USLCX (-5.94).
GFACXUSLCXGFACX / USLCX
Total Expense Ratio1.361.8872%
Annual Report Gross Expense Ratio1.361.8972%
Fund Existence24 years23 years-
Gain YTD11.2922.823400%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets323B2.09B15,484%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.11-12.72-56%
Returns for 3 years52.0123.32223%
Returns for 5 years35.91-5.94-605%
Returns for 10 years63.3118.10350%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp